TPCHRF - Round 6 - Pre-clinical assessment of poly-arginine R18 peptide as neuroprotective agent for perinatal hypoxic-ischaemic encephalopathy (HIE)

Project Details

StatusFinished
Effective start/end date1/07/1830/06/20

Funding

  • Government of Western Australia, Department of Health: AUD60,594.00
  • Government of Western Australia, Department of Health: AUD27,201.00
  • Government of Western Australia, Department of Health: AUD87,105.00